- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 9/74 - Thrombin
Patent holdings for IPC class C12N 9/74
Total number of patents in this class: 163
10-year publication summary
6
|
19
|
8
|
10
|
16
|
10
|
13
|
10
|
8
|
2
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Omrix Biopharmaceuticals Ltd. | 159 |
18 |
Gladiator Biosciences, Inc. | 15 |
11 |
Saint Louis University | 289 |
6 |
Ethicon, Inc. | 1310 |
5 |
Baxter International Inc. | 2425 |
5 |
Absci Corporation | 58 |
5 |
Arthrex, Inc. | 1201 |
4 |
Siemens Healthcare Diagnostics Products GmbH | 148 |
4 |
Absci, LLC | 10 |
3 |
Aronora, Inc. | 15 |
3 |
Osaka University | 3143 |
3 |
Guangzhou Bioseal Biotech Co., Ltd. | 29 |
3 |
SomaLogic Operating Co., Inc. | 230 |
3 |
Massachusetts Institute of Technology | 9795 |
2 |
Bio Products Laboratory Limited | 32 |
2 |
Biomet Biologics, LLC | 77 |
2 |
Canadian Blood Services | 82 |
2 |
Cleveland State University | 78 |
2 |
In2cure AB | 10 |
2 |
Mcmaster University | 746 |
2 |
Other owners | 76 |